Publications by authors named "Yokote H"

Background And Purpose: Slowly expanding lesions (SELs) have been proposed as novel MRI markers of chronic active lesions in multiple sclerosis (MS). However, the mechanism through which SELs affect brain volume loss in patients with MS remains unknown. Additionally, the prevalence and significance of SELs in Asian patients with MS remain unclear.

View Article and Find Full Text PDF

Progression independent of relapse activity (PIRA) is prevalent among Caucasian patients with relapsing and remitting multiple sclerosis (RRMS). However, there is limited knowledge regarding the characteristics of PIRA in Asian patients with RRMS. Therefore, we retrospectively analyzed the clinical and radiological progression of 95 Japanese patients with RRMS during a 2-year observation period.

View Article and Find Full Text PDF

Background: Neurodegenerative changes are observed in relapsing-remitting multiple sclerosis (RRMS) and are prominent in secondary progressive MS (SPMS). However, whether neurodegenerative changes accelerate and are altered after the transition into SPMS or in the presence of relapses remains uncertain.

Methods: In this study, 73 patients with MS (seven with relapsing RRMS, 56 with relapse-free RRMS, and 10 with relapse-free SPMS) were evaluated for brain segmental volume changes over a 2-year follow-up period.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates kidney iron deposition in patients with paroxysmal nocturnal hemoglobinuria (PNH) and its relationship to kidney damage.
  • The researchers used a method called IDEAL-IQ to measure kidney R2* values, finding significantly higher values in PNH patients compared to healthy individuals.
  • Results indicate that IDEAL-IQ could serve as a valuable non-invasive tool for assessing renal iron overload in PNH patients, correlating well with levels of lactate dehydrogenase (LDH), a marker of hemolysis.
View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) causes a systemic inflammatory response and a temporary immunosuppression of hosts. Several reports have showed that reactivation of herpes simplex virus type 1 (HSV-1) is strongly associated with COVID-19. We present a case of a 66-year-old female, who developed HSV-1 encephalitis, showing impaired consciousness and typical MRI findings such as hyperintense lesions in the temporal lobe, insular cortices, bilateral medial frontal lobe on diffusion-weighted imaging, 7 days after the onset of COVID-19 symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • A 75-year-old woman experienced nausea and vomiting, leading to an MRI that identified a pituitary mass and a biopsy confirming lymphocytic hypophysitis (LYH).
  • Treatment with hormone replacement therapy alleviated her symptoms, but follow-up imaging showed an increase in mass size, prompting treatment with intravenous methylprednisolone (IVMP), which reduced the mass but caused new vision-related issues.
  • Despite initial symptom improvement after IVMP, the mass progressed and involved nearby structures, resulting in internal carotid artery (ICA) stenosis that continued even after treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Eculizumab, a C5 inhibitor, is approved in Japan to prevent relapses in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+ NMOSD), and its long-term safety and effectiveness are being evaluated through post-marketing surveillance.
  • This interim analysis included data from patients treated with eculizumab from its approval in November 2019 to April 2022, assessing those who had reported safety and effectiveness outcomes.
  • Of the 147 patients treated, 71 were analyzed for safety, with notable demographics including a predominance of females and an average age of around 51; adverse events were reported by about 27% and no serious meningoc
View Article and Find Full Text PDF
Article Synopsis
  • Different treatment strategies in multiple sclerosis (MS) can impact disability and brain volume, but the relationship between brain volume changes and treatment efficacy remains unclear.
  • A study evaluated 44 patients with relapse-onset MS receiving either high-efficacy therapy (HET) or low-efficacy therapy (LET), measuring changes in regional brain volume using advanced MRI techniques.
  • Results showed that HET was linked to significant volume changes in key brain regions and a higher proportion of patients experiencing no disease activity, suggesting HET may enhance mid-term outcomes for MS patients.
View Article and Find Full Text PDF

Plasmacytoid urothelial carcinomas of the bladder are rare, aggressive variants with a poor prognosis. Few reports have described the correlation of histopathological features with multiparametric magnetic resonance imaging findings in the local staging of plasmacytoid urothelial carcinoma. An 82-year-old woman with hematuria was referred to our hospital.

View Article and Find Full Text PDF

Background Theory of mind (ToM) is one of the several different concepts in social cognition and is defined as the ability to access the mental states of others or to adopt the point of view of others. Although studies have shown that ToM is impaired in people with multiple sclerosis (MS), the results based on individual ToM tasks are conflicting; some studies have shown deficits only in the 'Reading the Mind in the Eyes' Test (RMET), while others have reported poor performance in the Faux Pas Test (FPT) as well as RMET. Furthermore, little is known about the relationship between ToM performance and neuroanatomical characteristics in MS.

View Article and Find Full Text PDF

It is unclear whether brain atrophy in multiple sclerosis (MS) is associated with not only neuroinflammation but also systemic inflammation. Here we found that systemic inflammatory marker serum amyloid A (SAA) was moderately correlated with cortical volume in the patients with clinically isolated syndrome (CIS) and MS (r = -0.41, p = 0.

View Article and Find Full Text PDF

Neuromyelitis optica spectrum disorder (NMOSD) affects the central nervous system but is rarely reported to cause peripheral nervous system damage. We report a case of a 57-year-old woman with numbness and muscle weakness of the left lower limb during the course of 12 years of anti-AQP4 antibody-positive NMOSD. Lumbar magnetic resonance imaging (MRI) showed a contrast effect on the left L4, L5, and S1 nerve roots, which is a highly unusual presentation.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the prevalence of PINK1 gene variants in 1,700 Parkinson's disease patients to understand their impact on the disease.
  • Researchers found that patients with homozygous PINK1 variants had an earlier onset of Parkinson's, indicating a correlation between variant type and age of onset.
  • Additionally, about half of the patients with heterozygous PINK1 variants showed reduced heart function, highlighting the clinical significance of these genetic variations in Parkinson's disease.
View Article and Find Full Text PDF

Background: Necrotizing myopathy (NM) is defined by the dominant pathological feature of necrosis of muscle fibers without substantial lymphocytic inflammatory infiltration. Anti-signal recognition particle (SRP)-antibody-positive myopathy is related to NM. Anti-SRP-antibody-positive myopathy can comorbid with other disorders in some patients, however, comorbidity with malignant tumor and myopericarditis has still not been reported.

View Article and Find Full Text PDF

A 69-year-old man was admitted with neck muscle weakness, symmetric proximal muscle weakness, skin rash and elevated serum creatine kinase levels. Muscle biopsy showed perifascicular necrosis and perimysial alkaline phosphatase activity. Chest CT revealed interstitial lung disease and colorectal cancer was diagnosed on colonoscopy.

View Article and Find Full Text PDF

No evidence of disease activity-3 (NEDA-3), defined as absence of clinical relapse, disability progression, and brain magnetic resonance imaging (MRI) activity, has emerged as the therapeutic target of disease-modifying therapy for multiple sclerosis (MS). However, recent studies have revealed that NEDA-3 might not be sufficient to prevent cognitive deterioration and predict long-term disability. In addition to NEDA-3, brain atrophy has recently been recognized as a pivotal biomarker that is closely associated to disability in patients with MS.

View Article and Find Full Text PDF

Purpose: Medication is an important risk factor for delirium; however, the association between delirium and prehospitalization medication is unclear. We investigated the association between prestroke medication and poststroke delirium.

Materials And Methods: All patients hospitalized in the stroke care unit from September 2011 to September 2012 were selected, and their delirium symptoms, patient information, and pre- and poststroke medications were analyzed.

View Article and Find Full Text PDF

Background: Although predicting future brain volume loss (BVL) in patients with multiple sclerosis (MS) is important, studies have shown only a few biomarkers that can predict BVL.

Objectives: The aim of this study is to elucidate the association between longitudinal BVL and serum biomarker candidates.

Methods: This single-center, retrospective, observational study intended to cover MS patients during January 2008 to March 2016.

View Article and Find Full Text PDF

Japanese botulinum antitoxins have been used for more than 50 years; however, their safety and therapeutic efficacy are not clear. In order to analyze the available data on botulinum antitoxin therapy in Japan, we surveyed published reports about botulism cases in which botulinum antitoxins were used, and retrospectively analyzed the safety and efficacy of the therapy. A total of 134 patients administered botulinum antitoxins were identified from published reports.

View Article and Find Full Text PDF

Background: In Japan, production of smallpox vaccine LC16m8 (named LC16-KAKETSUKEN) was restarted and was determined to be maintained as a national stockpile in March 2002.

Objective: To conduct a post-marketing surveillance study of the vaccination of freeze-dried live attenuated smallpox vaccine prepared in cell culture LC16-KAKETSUKEN using attenuated vaccinia strain LC16m8. The study complied with Good Clinical Practice, focusing on a comparison between primary vaccinees and re-vaccinees.

View Article and Find Full Text PDF